Kyle Kline - 18 Jul 2025 Form 3 Insider Report for GLOBUS MEDICAL INC (GMED)

Role: Senior Vice President, CFO
Signature: /s/ Kelly G. Huller, Attorney-in-Fact
Issuer symbol: GMED
Transactions as of: 18 Jul 2025
Transactions value $: $0
Form type: 3
Filing time: 27 Aug 2025, 18:08:38 UTC
Next filing: 03 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kline Kyle	Senior Vice President, CFO	VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE, AUDUBON	/s/ Kelly G. Huller, Attorney-in-Fact	27 Aug 2025	0002080625

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	GMED	Stock Option (Right to Buy Class A Common Stock)							18 Jul 2025	Class A Common Stock	5K	$64.44	Direct	F1
holding	GMED	Stock Option (Right to Buy Class A Common Stock)							18 Jul 2025	Class A Common Stock	5K	$80.17	Direct	F2
holding	GMED	Stock Option (Right to Buy Class A Common Stock)							18 Jul 2025	Class A Common Stock	5K	$63.68	Direct	F3
holding	GMED	Stock Option (Right to Buy Class A Common Stock)							18 Jul 2025	Class A Common Stock	5K	$53.14	Direct	F4
holding	GMED	Stock Option (Right to Buy Class A Common Stock)							18 Jul 2025	Class A Common Stock	15K	$56.43	Direct	F5
holding	GMED	Stock Option (Right to Buy Class A Common Stock)							18 Jul 2025	Class A Common Stock	7.5K	$51.87	Direct	F6
holding	GMED	Stock Option (Right to Buy Class A Common Stock)							18 Jul 2025	Class A Common Stock	9.09K	$93.12	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options were granted on January 25, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F2	These options were granted on August 9, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on July 12, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F3	These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F4	These options were granted on March 24, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F5	These options were granted on February 27, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F6	These options were granted on March 14, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F7	These options were granted on January 30, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.